Kama Basci, O.; Oral, A.; Kirik, A.; Sen, H.; Solmaz, I.; Topaloglu, U.S.; Demir, I.; Dundar, A.; Binnetoglu, E.; Okuroglu, N.;
et al. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics 2026, 16, 547.
https://doi.org/10.3390/diagnostics16040547
AMA Style
Kama Basci O, Oral A, Kirik A, Sen H, Solmaz I, Topaloglu US, Demir I, Dundar A, Binnetoglu E, Okuroglu N,
et al. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics. 2026; 16(4):547.
https://doi.org/10.3390/diagnostics16040547
Chicago/Turabian Style
Kama Basci, Ozge, Alihan Oral, Ali Kirik, Hacer Sen, Ihsan Solmaz, Ulas Serkan Topaloglu, Ismail Demir, Ahmet Dundar, Emine Binnetoglu, Nalan Okuroglu,
and et al. 2026. "Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study" Diagnostics 16, no. 4: 547.
https://doi.org/10.3390/diagnostics16040547
APA Style
Kama Basci, O., Oral, A., Kirik, A., Sen, H., Solmaz, I., Topaloglu, U. S., Demir, I., Dundar, A., Binnetoglu, E., Okuroglu, N., Aydin, A., Kaya, Z. I., Yildiz, H., Acet, A., Tazegul, G., Ozudogru, O., Issever, K., Yaylacı, S., Korkmaz, U. B.,
... Sözel, H.
(2026). Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics, 16(4), 547.
https://doi.org/10.3390/diagnostics16040547